sitagliptin
Ligand Summary
A pyrazine-derived DIPEPTIDYL-PEPTIDASE IV INHIBITOR and HYPOGLYCEMIC AGENT that increases the levels of the INCRETIN hormones GLUCAGON-LIKE PEPTIDE-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). It is used in the treatment of TYPE 2 DIABETES.
UNII: QFP0P1DV7Z
PubChem: 4369359
PubChem: 6451150
PubChem: 11476287
Guide to Pharmacology: 6286
ChEMBL: CHEMBL1422
ChEMBL: CHEMBL393336
ChEMBL: CHEMBL539077
DrugCentral: 2448
LyCHI: 1CS459QWD6NB
Target Activities
64 Activities
Items per page:
1 – 10 of 64
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
IC50 | ||||||
IC50 | ||||||
Kd | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||